Evaluation of Subclinical Cardiovascular Disease by Carotid Intima Media Thickness, Epicardial Adipose Tissue Thickness, Serum Endocan, and Nesfatin-1 Levels in Patients with Primary Hyperparathyroidism

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2022 Nov 3

PMID 36326370

Authors

Muhammet Kocabas

Yakup Alsancak

Mustafa Can

Ilker Cordan

Hatice Caliskan Burgucu

Melia Karakose

Fatma Humeyra Yerlikaya

Mustafa Kulaksizoglu

Feridun Karakurt

Affiliations

Soon will be listed here.

Abstract

Background: Data on the presence and extent of cardiovascular disease (CVD) risk in primary hyperparathyroidism (PHPT) are conflicting. In our study, we aimed to investigate the increased CVD risk in patients with PHPT by carotid intima-media thickness (CIMT), epicardial adipose tissue (EAT) thickness, and serum levels of endocan and nesfatin-1.

Methods: Patients with PHPT (n = 44) and age- and sex-matched healthy control subjects (n = 40) were enrolled in this study. Demographic data of the participants were questioned. Serum endocan and nesfatin-1 concentrations were assessed using commercially available ELISA kits. Noninvasive measurements of CIMT and EAT thickness were made with high-resolution ultrasonography and B-mode echocardiography.

Results: There was no statistically significant difference in serum endocan and nesfatin-1 levels and EAT thickness in the PHPT group compared to controls. CIMT was statistically significantly higher in the PHPT group compared to controls (p = 0.001). A negative correlation was found between PTH and low-density lipoprotein cholesterol level (p = 0.001) but no significant relationship was found between other parameters.

Discussion: We found that CIMT is increased in patients with PHPT and consequently, CVD risk is high in these patients. More comprehensive studies are needed to identify other markers that predict increased CVD risk in patients with PHPT.

References

Kosch M, Hausberg M, Barenbrock M, Posadzy-Malaczynska A, Kisters K, Rahn K . Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin Nephrol. 2001; 55(4):303-8. View

Stamatelopoulos K, Athanasouli F, Pappa T, Lambrinoudaki I, Papamichael C, Polymeris A . Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 2014; 99(8):2704-11. DOI: 10.1210/jc.2013-4273. View

Cansu G, Yilmaz N, Ozdem S, Balci M, Suleymanlar G, Arici C . Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol (Oxf). 2015; 84(1):39-47. DOI: 10.1111/cen.12952. View

Cimen T, Efe T, Akyel A, Sunman H, Algul E, Sahan H . Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina. Angiology. 2016; 67(9):846-53. DOI: 10.1177/0003319715625827. View

Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K . Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006; 443(7112):709-12. DOI: 10.1038/nature05162. View

Stefenelli T, Abela C, Frank H, Globits S, Bergler-Klein J, Niederle B . Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab. 1997; 82(1):106-12. DOI: 10.1210/jcem.82.1.3666. View

Bechard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M . Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001; 167(6):3099-106. DOI: 10.4049/jimmunol.167.6.3099. View

Lumachi F, Ermani M, Frego M, Pilon F, Filosa T, Di Cristofaro L . Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up. In Vivo. 2007; 20(6B):887-90. View

Aeddula N, Cheungpasitporn W, Thongprayoon C, Pathireddy S . Epicardial Adipose Tissue and Renal Disease. J Clin Med. 2019; 8(3). PMC: 6463003. DOI: 10.3390/jcm8030299. View

10.

Schluter K, Piper H . Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res. 1998; 37(1):34-41. DOI: 10.1016/s0008-6363(97)00194-6. View

11.

Mazurek T, Zhang L, Zalewski A, Mannion J, Diehl J, Arafat H . Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003; 108(20):2460-6. DOI: 10.1161/01.CIR.0000099542.57313.C5. View

12.

Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P . Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf). 2002; 56(2):253-60. DOI: 10.1046/j.0300-0664.2001.01468.x. View

13.

Tassone F, Maccario M, Gianotti L, Baffoni C, Pellegrino M, Cassibba S . Insulin sensitivity in normocalcaemic primary hyperparathyroidism. Endocrine. 2013; 44(3):812-4. DOI: 10.1007/s12020-013-0059-z. View

14.

Balta S, Mikhailidis D, Demirkol S, Ozturk C, Celik T, Iyisoy A . Endocan: A novel inflammatory indicator in cardiovascular disease?. Atherosclerosis. 2015; 243(1):339-43. DOI: 10.1016/j.atherosclerosis.2015.09.030. View

15.

Kose M, Emet S, Akpinar T, Kocaaga M, Cakmak R, Akarsu M . Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study. Angiology. 2014; 66(8):727-31. DOI: 10.1177/0003319714548870. View

16.

Anderson J, Vanwoerkom R, Horne B, Bair T, May H, Lappe D . Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?. Am Heart J. 2011; 162(2):331-339.e2. DOI: 10.1016/j.ahj.2011.05.005. View

17.

Cimen T, Bilgin M, Akyel A, Felekoglu M, Nallbani A, Ozdemir S . Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension. Korean Circ J. 2016; 46(6):827-833. PMC: 5099339. DOI: 10.4070/kcj.2016.46.6.827. View

18.

Nickols G . Increased cyclic AMP in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur J Pharmacol. 1985; 116(1-2):137-44. DOI: 10.1016/0014-2999(85)90194-3. View

19.

Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn K, Barenbrock M . Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens. 2000; 13(7):759-64. DOI: 10.1016/s0895-7061(00)00248-x. View

20.

Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, Mosquera-Leal A, Gonzalez-Juanatey J, Lago F . Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level. Endocrine. 2015; 52(1):11-29. DOI: 10.1007/s12020-015-0819-z. View